RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.



rapt.com

Biotechnology

South San Francisco, California, United States

Rapt Therapeutics announced it raised $150 Million in an initial filing from an offering of $150 Million

Company Information

Related People

Funding Insights

Rapt Therapeutics announced it raised $150 Million in an initial filing from an offering of $150 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information